John Norton, 1999 graduate of West Chicago Community High School, is the Senior Scientist and Business Development Lead at Monopar Therapeutics in Wilmette. Athird drug that is being progressed toward the first stages of clinical trials is a host-targeted drug that will hopefully treat the most severe COVID-19 patients, allowing them to bypass ventilator mediation and prevent organ failure and death.